Unique Tumor Heterogeneity Within a Single Locally Advanced Basal Cell Carcinoma Resulting in a Partial Response Despite Continuous Vismodegib Treatment
Authors:
- 1 April 2019
- journal article
- letter
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 45 (4) , 608-610
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Surgical Excision After Neoadjuvant Therapy With Vismodegib for a Locally Advanced Basal Cell Carcinoma and Resistant Basal Carcinomas in Gorlin SyndromeJAMA Dermatology, 2013
- Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell CarcinomaArchives of Dermatology, 2012
- Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug ResistanceCancer Research, 2011
- Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449New England Journal of Medicine, 2009